Apr 26 2025

Edible Cannabis Possession Limits Across the 24 Legal Marijuana States (as of April 2025)

As of April 2025, 24 U.S. states have legalized adult-use marijuana. In each of these states, it varies significantly how much cannabis edibles, in both solid and liquid forms, an individual is allowed to possess.

Most states regulate edibles based on THC content rather than by the total weight of the edible product, but that’s not always the case. Below is a complete breakdown of each state’s edible possession rules for recreational users, along with any differences that apply to medical marijuana patients. In each state, the age limit is 21 and older, unless for medical purposes.

Continue reading

Apr 26 2025

National Survey Finds Two-Thirds of Voters Support Legalizing Marijuana, Including Majority of Republicans

A new national poll shows that voters across all political affiliations overwhelmingly support legalizing recreational marijuana, in addition to backing a series of reforms such as reschuling.

The survey, conducted by Fabrizio, Lee & Associates, found that 66% of registered voters favor legalization, compared to just 25% opposed. Among Republicans and Republican-leaning voters, support stood at 53% in favor and 37% opposed. Support was strongest among voters under 35, with 78% favoring legalization, but even voters 65 and older backed the move by a margin of 50% to 38%.

Support also extends to efforts to reschedule marijuana under federal law. Seventy-two percent of all voters, including 67% of Republican-aligned voters, favor moving marijuana from Schedule I to Schedule III, a shift that would recognize accepted medical use and ease research restrictions.
Continue reading

Apr 26 2025

Study: Psilocybin Quickly Reduces Depression and Anxiety Symptoms in Cancer Patients

Published by The International Journal of Psychiatry in Medicine, a new study found that psilocybin may quickly reduce depression and anxiety symptoms in cancer patients.

The research was conducted by scientists from LUXMED Group, the John Paul II Catholic University of Lublin, and the Medical University of Gdansk in Poland, the International European University in Ukraine, and the Baylor College of Medicine in Texas. Researchers performed a systematic review and network meta-analysis of randomized controlled trials, following PRISMA and Cochrane Handbook guidelines. Databases including PubMed, Embase, and the Cochrane Library were analyzed through July 2024.

Ultimately, two randomized controlled trials met the study’s inclusion criteria. Investigators assessed changes in Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI) scores on day 1 following psilocybin administration and again at a two-week follow-up.
Continue reading

Apr 26 2025

Study: CBD-Loaded Nanoparticles Show Potential for Treating Metabolic Disorders

Researchers in Spain have developed a novel CBD-based nanoparticle system that could improve the management of metabolic diseases, according to a study published in the Journal of Biomedical Materials Research Part A.

The study, conducted by researchers from Universidad de Sevilla, University of Cádiz, Universitario Virgen del Rocío, and Universidad de Cantabria, focused on creating polymeric nanoparticles (NPs) using poly(lactic-co-glycolic acid) (PLGA) to encapsulate CBD. These nanoparticles, which measured between 135 and 265 nanometers, demonstrated nearly 100% encapsulation efficiency and offered sustained release properties.

The therapeutic potential of the CBD-loaded nanoparticles was tested using an in vitro model of metabolic syndrome. Researchers exposed HepG2 liver cells to sodium palmitate and evaluated parameters such as cell viability, glucose uptake, lipid accumulation, triglyceride and cholesterol levels, and gene expression related to metabolism.
Continue reading

Apr 25 2025

Colorado Senate Approves Bill to Modernize Marijuana Regulations in 25 to 10 Vote

The Colorado Senate has approved a bill that’s designed to modernize the state’s marijuana regulations, passing it today by a vote of 25 to 10.

The measure, House Bill 1209, proposes major reforms to licensing, compliance, and research rules, and now returns to the House for a final concurrence vote before heading to the governor’s desk.

House Bill 1209, which previously passed the House 45 to 18 and is sponsored by Representative William Lindstedt and a group of bipartisan lawmakers, would raise the purchase limit for retail marijuana from one ounce to two ounces, authorize promotional giveaways under strict conditions, and allow marijuana businesses to use digital notifications instead of mailed letters for regulatory communications.
Continue reading

Apr 25 2025

Florida House Unanimously Passes Bill to Waive Medical Marijuana Card Fees for Veterans, Extend Validity Period to Two Years

In a unanimous 110 to 0 vote today, the Florida House approved a bill that would waive medical marijuana card fees for veterans and extend the validity of all cards from one year to two.

House Bill 555 would eliminate the state’s fee for issuing, renewing, or replacing medical marijuana identification cards for veterans who have received an honorable discharge. Applicants would need to provide a DD-214 form to verify their status.

Beyond the fee waiver for veterans, the bill would extend the expiration date for all medical marijuana ID cards—regardless of veteran status—from one year to two years, helping to lower costs and reduce the burden of frequent renewals for patients and caregivers.
Continue reading

Apr 25 2025

The Five States Working to Put Cannabis Initiatives to a Public Vote in 2026

As the national conversation around cannabis reform continues to evolve, proponents in several states are working to put marijuana-related initiatives before voters in the November 2026 elections.

Among these are Florida, Idaho, and Oklahoma, where advocacy groups are actively working to qualify measures for next year’s ballot. These initiatives would legalize or decriminalize cannabis, reflecting a growing trend toward reevaluating marijuana laws across the United States.​

Continue reading

Apr 25 2025

CBD Demonstrates “Significant Anticancer Effects” Against Breast Cancer: Study

According to a new study published in BMC Cancer, “CBD demonstrated significant anticancer effects, including induction of apoptosis, inhibition of cell proliferation, suppression of metastasis, and modulation of the tumor microenvironment.”

“Breast cancer is one of the most prevalent cancers worldwide, posing significant challenges due to its heterogeneity and the emergence of drug resistance”, states the study’s abstract. “Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, has recently gained attention for its potential therapeutic effects in breast cancer.”

With that in mind, this study “aims to evaluate the antitumor effects of CBD in breast cancer treatment by synthesizing preclinical and clinical evidence, elucidating its mechanisms of action, and exploring its translational potential.”
Continue reading

Apr 25 2025

Montana Lawmakers Give Final Approval to Resolution Urging U.S. Congress to Enact Cannabis Banking Legislation

The Montana House of Representatives today gave final approval to Senate Joint Resolution 5, a measure urging the U.S. Congress to pass the SAFER Banking Act. The resolution cleared its third and final reading in a 65 to 35 vote, five more votes in favor than during its second reading.

Having already passed the Senate last month in a 35 to 14 vote, the resolution is now officially enacted. As a resolution rather than a bill, it does not require the governor’s signature and will now be transmitted to Congress.

SJR 5 calls on Congress to advance the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which would allow financial institutions to provide standard banking services to state-licensed marijuana businesses. These services would include checking accounts, loans, and debit processing, while also allowing such businesses to access federal tax deductions currently unavailable due to marijuana’s status under federal law.
Continue reading

Apr 25 2025

Canada Marijuana Sales Top CA$400 Million in February, CA$837 Million So Far in 2025

There was CA$404,708,00 worth of marijuana and marijuana products sold legally in Canada in February, according to new data released today by Statistics Canada.

Februarys sales totals are a slight increase from the CA$402 million sold in February 2024, but are below the CA$437 million sold in January. So far in 2025, the nation’s legal cannabis market has generated nearly CA$850 million in sales.

Ontario led the nation in million in sales with CA$162 million, followed by Alberta with CA$73 million. British Columbia came in third with CA$58 million, Quebec was fourth with CA$42 million, and Manitoba rounded out the top five with CA$20 million. Of these top five providences, only Manitoba saw increased sales from January to February.
Continue reading